Literature DB >> 10899446

Cerebrotendinous xanthomatosis. Controversies about nerve and muscle: observations in ten patients.

A Verrips1, B G van Engelen, H ter Laak, A Gabreëls-Festen, A Janssen, M Zwarts, R A Wevers, F J Gabreëls.   

Abstract

Neuromuscular characteristics were documented in ten patients with biochemically and genetically confirmed cerebrotendinous xanthomatosis. An array of genotypes was found in these patients. Only one patient complained of muscle weakness, while clinical signs of peripheral neuropathy were present in six patients. Electromyogram showed predominantly axonal neuropathy in seven patients. Neurogenic changes were seen in muscle biopsies of nine patients. Sural nerve biopsies of three patients showed features of axonal neuropathy. In addition, in one patient, extensive onion bulb formation was seen, which is indicative of a primarily demyelinating process. Five patients had normal mitochondrial respiratory chain enzyme activity. It is concluded that myopathy is not a feature of cerebrotendinous xanthomatosis and that the most prominent neuromuscular abnormality is sensorimotor axonal polyneuropathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899446     DOI: 10.1016/s0960-8966(00)00112-7

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  11 in total

1.  Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid.

Authors:  F Ginanneschi; A Mignarri; M Mondelli; G N Gallus; M Del Puppo; S Giorgi; A Federico; A Rossi; M T Dotti
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

2.  Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees.

Authors:  M H Lee; S Hazard; J D Carpten; S Yi; J Cohen; G T Gerhardt; G Salen; S B Patel
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

Review 3.  Peripheral neuropathy and inborn errors of metabolism in adults.

Authors:  F Sedel; C Barnerias; O Dubourg; I Desguerres; O Lyon-Caen; Jean-Marie Saudubray
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

4.  Mutation of the sterol 27-hydroxylase gene ( CYP27A1) in a Taiwanese family with cerebrotendinous xanthomatosis.

Authors:  Ming-Jen Lee; Yuan-Chung Huang; Mary G Sweeney; Nicholas W Wood; Mary M Reilly; Ping-Keung Yip
Journal:  J Neurol       Date:  2002-09       Impact factor: 4.849

Review 5.  Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).

Authors:  Gerald Salen; Robert D Steiner
Journal:  J Inherit Metab Dis       Date:  2017-10-04       Impact factor: 4.982

6.  Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings.

Authors:  Adam J Guenzel; Andrea DeBarber; Kimiyo Raymond; Radhika Dhamija
Journal:  JIMD Rep       Date:  2021-01-08

7.  Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis.

Authors:  Shu-Fang Chen; Nai-Wen Tsai; Chung-Chih Chang; Cheng-Hsien Lu; Chi-Ren Huang; Yao-Chung Chuang; Wen-Neng Chang
Journal:  BMC Neurol       Date:  2011-05-31       Impact factor: 2.474

Review 8.  Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.

Authors:  Shuke Nie; Guiqin Chen; Xuebing Cao; Yunjian Zhang
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

9.  Sonographic Findings of Polyneuropathy Associated With Cerebrotendinous Xanthomatosis: A Case Report.

Authors:  Jung Yoon Yoon; Min-Wook Kim; Hyun Jung Do; Dae-Hyun Jang; Hee Won Lee
Journal:  Ann Rehabil Med       Date:  2017-04-27

10.  Cerebrotendinous xanthomatosis with peripheral neuropathy: a clinical and neurophysiological study in Chinese population.

Authors:  Shu Zhang; Wei Li; Rui Zheng; Bing Zhao; Yongqing Zhang; Dandan Zhao; Cuiping Zhao; Chuanzhu Yan; Yuying Zhao
Journal:  Ann Transl Med       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.